Compare CDNA & SLRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CDNA | SLRC |
|---|---|---|
| Founded | 1998 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 803.0M |
| IPO Year | 2007 | 2007 |
| Metric | CDNA | SLRC |
|---|---|---|
| Price | $17.06 | $13.80 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 7 | 6 |
| Target Price | ★ $27.33 | $15.58 |
| AVG Volume (30 Days) | ★ 539.5K | 308.8K |
| Earning Date | 05-13-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 11.53% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 1.70 |
| Revenue | ★ $48,324,000.00 | N/A |
| Revenue This Year | $15.37 | $1.09 |
| Revenue Next Year | $11.23 | N/A |
| P/E Ratio | ★ N/A | $8.36 |
| Revenue Growth | ★ 18.93 | N/A |
| 52 Week Low | $10.96 | $13.64 |
| 52 Week High | $21.49 | $17.26 |
| Indicator | CDNA | SLRC |
|---|---|---|
| Relative Strength Index (RSI) | 37.34 | 32.05 |
| Support Level | $16.74 | N/A |
| Resistance Level | $17.09 | $15.52 |
| Average True Range (ATR) | 0.83 | 0.38 |
| MACD | -0.21 | -0.07 |
| Stochastic Oscillator | 23.77 | 0.00 |
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.
SLR Investment Corp is a closed-end externally managed, non-diversified management investment company that has elected to be treated as a business development company. It provides U.S. middle market businesses and intermediaries with bespoke debt financing solutions to fund working capital, acquisition, refinancing and growth capital requirements. The company's investment objective is to generate both current income and capital appreciation through debt and equity investments. The company invests principally in leveraged middle-market companies in the form of senior secured loans, financing leases, and to a lesser extent, unsecured loans and equity securities.